Xtant Medical Holdings, Inc. (XTNT)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Development, Manufacture and Marketing of Orthopedic Medical Products & Devices			91.30M	57.97M	55.26M	53.34M	64.68M
Development, Manufacture and Marketing of Orthopedic Medical Products & Devices Growth			57.50%	4.90%	3.61%	-17.54%	-10.42%
Total			91.30M	57.97M	55.26M	53.34M	64.68M
Total Growth			57.50%	4.90%	3.61%	-17.54%	-10.42%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States			85.86M	57.16M	54.57M	52.15M	62.38M
United States Growth			50.21%	4.75%	4.65%	-16.40%	-9.44%
Rest of World			5.44M	807.00K	693.00K	1.19M	2.31M
Rest of World Growth			574.23%	16.45%	-41.76%	-48.37%	-30.63%
Total			91.30M	57.97M	55.26M	53.34M	64.68M
Total Growth			57.50%	4.90%	3.61%	-17.54%	-10.42%

Source: S&P Global Market Intelligence.